Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Globalization, Patents and Drugs (Second Edition). An Annotated Bibliography - Health Economics and Drugs Series No. 010
(2001; 52 pages) Voir le document au format PDF
Abrégé
Many WHO Member States have expressed concern about the effects of the TRIPS Agreement on access to pharmaceuticals and, in May 1999, the World Health Assembly mandated WHO “to cooperate with Member States, at their request, and with international organizations in monitoring and analysing the pharmaceutical and public health implications of relevant international agreements, including trade agreements.” The TRIPS Agreement is one of the most controversial of the Uruguay Round in terms of content, objectives and possible consequences. This annotated bibliography aims to inform people in the health sector, with no particular legal background, about the impact of globalization and trade agreements on access to drugs, and the growing importance of this issue. It directs the reader to key reports, books and articles from technical and scientific journals, both general references and specific country studies. Details of some useful web sites are also given.
Table des matières
Afficher le documentAbbreviations and acronyms
Afficher le documentIntroduction
Afficher le document1. General articles
Ouvrir ce répertoire et afficher son contenu2. Country studies by region
Ouvrir ce répertoire et afficher son contenu3. Electronic information
 

Globalization, Patents and Drugs (Second Edition). An Annotated Bibliography - Health Economics and Drugs Series No. 010

Second Edition (EDM/PAR/2001.1, 52 p.)

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019